ATE516502T1 - Nachweis des westnil-virus - Google Patents

Nachweis des westnil-virus

Info

Publication number
ATE516502T1
ATE516502T1 AT05741796T AT05741796T ATE516502T1 AT E516502 T1 ATE516502 T1 AT E516502T1 AT 05741796 T AT05741796 T AT 05741796T AT 05741796 T AT05741796 T AT 05741796T AT E516502 T1 ATE516502 T1 AT E516502T1
Authority
AT
Austria
Prior art keywords
west nile
nile virus
wnv
detection
infected
Prior art date
Application number
AT05741796T
Other languages
English (en)
Inventor
Katherine Esty
Ramaswamy Chandrashekar
Original Assignee
Idexx Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idexx Lab Inc filed Critical Idexx Lab Inc
Application granted granted Critical
Publication of ATE516502T1 publication Critical patent/ATE516502T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT05741796T 2004-04-28 2005-04-27 Nachweis des westnil-virus ATE516502T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/834,424 US7074555B2 (en) 2004-04-28 2004-04-28 Detection of West Nile Virus
PCT/US2005/014564 WO2005106483A1 (en) 2004-04-28 2005-04-27 Detection of west nile virus

Publications (1)

Publication Number Publication Date
ATE516502T1 true ATE516502T1 (de) 2011-07-15

Family

ID=34967870

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05741796T ATE516502T1 (de) 2004-04-28 2005-04-27 Nachweis des westnil-virus

Country Status (4)

Country Link
US (1) US7074555B2 (de)
EP (1) EP1745291B1 (de)
AT (1) ATE516502T1 (de)
WO (1) WO2005106483A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7425437B2 (en) * 1999-11-26 2008-09-16 Crucell Holland B.V. Vaccines against West Nile Virus
CA2591665C (en) * 2004-12-20 2015-05-05 Crucell Holland B.V. Binding molecules capable of neutralizing west nile virus and uses thereof
CA2608058C (en) 2005-05-12 2013-09-10 Crucell Holland B.V. Host cell specific binding molecules capable of neutralizing viruses and uses thereof
WO2006136601A1 (en) * 2005-06-23 2006-12-28 Crucell Holland B.V. Optimization of west nile virus antibodies
DK2027155T3 (en) * 2006-06-06 2016-05-09 Crucell Holland Bv HUMAN BINDING MOLECULES with killer activity against staphylococci and uses thereof
US20080044808A1 (en) * 2006-08-15 2008-02-21 Qian-Li Song West nile virus antigen and assay
EP3779445A1 (de) 2014-08-01 2021-02-17 Board of Supervisors of Louisiana State University and Agricultural and Mechanical College Nachweis und behandlung von bovinem herpesvirus
JP6976621B1 (ja) 2021-02-04 2021-12-08 株式会社Icst 検査器具、検査キットおよび検査方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7227011B2 (en) 1998-06-04 2007-06-05 United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Nucleic acid vaccines for prevention of flavivirus infection
FR2794865B1 (fr) 1999-06-09 2003-04-18 Pasteur Institut Methode de detection precoce des flavivirus et ses applications
AU2001268381A1 (en) * 2000-06-12 2001-12-24 Conoco Inc. Fischer-tropsch processes and catalysts using polyacrylate matrix structures
US6960360B2 (en) * 2000-08-31 2005-11-01 Phenolics, Llc Efficient method for producing compositions enriched in total phenols
US20030148261A1 (en) * 2001-03-12 2003-08-07 Erol Fikrig Compositions and methods comprising West Nile virus polypeptides
US20030104008A1 (en) * 2001-04-06 2003-06-05 Loosmore Sheena May Recombinant vaccine against west nile virus
US20040037848A1 (en) * 2001-04-06 2004-02-26 Audonnet Jean-Christophe Francis Recombinant vaccine against West Nile Virus
ES2435095T3 (es) * 2001-07-27 2013-12-18 Zoetis W Llc Vacuna del Nilo Occidental
BR0315935A (pt) 2002-10-31 2005-09-20 Health Research Inc Teste de diagnóstico para o vìrus do nilo ocidental
US7585621B2 (en) 2003-09-09 2009-09-08 Idexx Laboratories, Inc. Detection of West Nile virus infection and vaccination

Also Published As

Publication number Publication date
EP1745291B1 (de) 2011-07-13
EP1745291A1 (de) 2007-01-24
US7074555B2 (en) 2006-07-11
US20050244814A1 (en) 2005-11-03
WO2005106483A1 (en) 2005-11-10

Similar Documents

Publication Publication Date Title
TW200512457A (en) Method of diagnosing SARS corona virus infection
TW200604526A (en) Identifying virally infected and vaccinated organisms
DE50113548D1 (de) Verfahren zum Nachweis von Influenza A/B-Viren in Speichel
DE60300339D1 (de) Verfahren zum Nachweis von Karzinomen in solubilisierten zervikalen Körperproben
MX340547B (es) Equipos de prueba de diagnostico.
WO2004016586A3 (en) Compositions and methods related to flavivirus envelope protein domain iii antigens
Alvarez et al. The efficacy of ELISA commercial kits for the screening of equine infectious anemia virus infection
KR920701481A (ko) 장을 통해 전염되는 비a비b형 간염 바이러스 병원체 및 그것의 특유한 에피토프
ATE519108T1 (de) Detektion von analyten in fäkalproben
Panei et al. Serological evidence of SARS-CoV-2 infection in pets naturally exposed during the COVID-19 outbreak in Argentina
BRPI0200986B8 (pt) método de determinação da presença de hcv em uma amostra
SG135990A1 (en) Competitive enzyme linked immunosorbent assay (c-elisa) for the detection of a flavivirus specific antibody
WO2005024427A3 (en) Detection of west nile virus infection and vaccination
ATE534729T1 (de) Hepatitis-b-virus-dna-polymerase und oberflächenantigen-varianten und methoden iher verwendung
DE60239715D1 (de) Nachweis des bovinen Virusdiarrhoe-Virus in Gewebeproben
Chau et al. Absence of SARS-CoV-2 antibodies in pre-pandemic plasma from children and adults in Vietnam
MX2010005713A (es) Metodo y kit para detectar virus de diarrea viral bovina en muestras tisulares.
JP2005538343A5 (de)
EA200700345A1 (ru) Обогащённое антитело для выявления микобактериальной инфекции, способы применения и диагностические тесты, применяющие такое антитело
Van der Wal et al. A bead-based suspension array for the serological detection of Trichinella in pigs
ES2674672T3 (es) Péptidos de interferencia y procedimiento de detección de microorganismos
ATE426038T1 (de) Nachweis des rinderdiarrhoevirus in haarproben
ATE434763T1 (de) Verfahren zum nachweis des felinen immunschwächevirus
SG165194A1 (en) Point of care test for the detection of exposure to hev immunoglobulin a (iga)
DE602005027326D1 (de) Verfahren und vorrichtung zum nachweis von katzen-immunschwächevirus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties